Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrew P. Holmes
Andrew P. Holmes
GlaxoSmithKline
Oncology
Internal medicine
Medicine
Multiple myeloma
genetically engineered
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of letetresgene autoleucel (lete-cel; GSK3377794) in advanced myxoid/round cell liposarcoma (MRCLS) following high lymphodepletion (Cohort 2): Interim analysis.
2021
Journal of Clinical Oncology
Sandra P. DAngelo
Mihaela Druta
Brian A. Van Tine
David A. Liebner
Scott M. Schuetze
Aisha N. Hasan
Andrew P. Holmes
Anne Huff
Gurpreet Kapoor
Stefan Zajic
Neeta Somaiah
Show All
Source
Cite
Save
Citations (0)
Open-label pilot study of genetically engineered NY-ESO-1–specific t cells (GSK3377794) alone or in combination with pembrolizumab in relapsed/refractory multiple myeloma.
2020
Journal of Clinical Oncology
Aaron P. Rapoport
James E. Hoffman
Jonathan L. Kaufman
Kristin Blouch
Emily Butler
Maurice P. Deyoung
Benedetto Farsaci
Aisha N. Hasan
Andrew P. Holmes
Anne Huff
Amit Jain
Michael Jon Chisamore
Taiga Nishihori
Show All
Source
Cite
Save
Citations (1)
1